skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Búsqueda Sencilla
Resultados 1 2 3 4 5 next page
Mostrar solo
Refinado por: colección: BioMed Central eliminar colección: Open Access: PubMed Central eliminar
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Ethical challenges with the left ventricular assist device as a destination therapy
Ethical challenges with the left ventricular assist device as a destination therapy
Material Type:
Artículo 		Añadir a Mi Portal

Ethical challenges with the left ventricular assist device as a destination therapy

Rizzieri, Aaron G ; Verheijde, Joseph L ; Rady, Mohamed Y ; McGregor, Joan L

Philosophy, ethics, and humanities in medicine : PEHM, 2008-08, Vol.3 (1), p.20-20, Article 20 [Revista revisada por pares]

England: BioMed Central Ltd

Texto completo disponible

Citas Citado por
2
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
Material Type:
Artículo 		Añadir a Mi Portal

Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery

Green, Michael M B ; Chao, Nelson ; Chhabra, Saurabh ; Corbet, Kelly ; Gasparetto, Cristina ; Horwitz, Ari ; Li, Zhiguo ; Venkata, Jagadish Kummetha ; Long, Gwynn ; Mims, Alice ; Rizzieri, David ; Sarantopoulos, Stefanie ; Stuart, Robert ; Sung, Anthony D ; Sullivan, Keith M ; Costa, Luciano ; Horwitz, Mitchell ; Kang, Yubin

Journal of hematology and oncology, 2016-08, Vol.9 (1), p.71-71, Article 71 [Revista revisada por pares]

England: BioMed Central Ltd

Texto completo disponible

Citas Citado por
3
355 First-in-human phase I study of NKTR-255 in patients with relapsed/refractory hematologic malignancies
355 First-in-human phase I study of NKTR-255 in patients with relapsed/refractory hematologic malignancies
Material Type:
Artículo 		Añadir a Mi Portal

355 First-in-human phase I study of NKTR-255 in patients with relapsed/refractory hematologic malignancies

Shah, Nina ; Tan, Alan ; Budde, Lihua ; Hofmeister, Craig ; Cowan, Andrew ; Saeed, Hayder ; Ye, Jing ; Cairo, Mitchell ; Rizzieri, David ; Orloff, Gregory ; Ge, Xue Snow ; Lee, Zachary ; Dixit, Neha ; Nieves, Wildaliz ; Vimal, Mona ; Ma, Haijun ; Miyazaki, Takahiro ; Madakamutil, Loui ; Marcondes, Mario ; Lin, Wei ; Tagliaferri, Mary ; Zalevsky, Jonathan ; Patel, Krina

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A216-A217 [Revista revisada por pares]

London: BMJ Publishing Group LTD

Texto completo disponible

Citas Citado por
4
Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions
Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions
Material Type:
Artículo 		Añadir a Mi Portal

Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions

Samra, Bachar ; Jabbour, Elias ; Ravandi, Farhad ; Kantarjian, Hagop ; Short, Nicholas J

Journal of hematology and oncology, 2020-06, Vol.13 (1), p.70-70, Article 70 [Revista revisada por pares]

England: BioMed Central Ltd

Texto completo disponible

Citas Citado por
5
Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas
Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas
Material Type:
Artículo 		Añadir a Mi Portal

Deep sequencing reveals clonal evolution patterns and mutation events associated with relapse in B-cell lymphomas

Jiang, Yanwen ; Redmond, David ; Nie, Kui ; Eng, Ken W ; Clozel, Thomas ; Martin, Peter ; Tan, Leonard Hc ; Melnick, Ari M ; Tam, Wayne ; Elemento, Olivier

Genome biology, 2014-08, Vol.15 (8), p.432-432, Article 432 [Revista revisada por pares]

England: BioMed Central Ltd

Texto completo disponible

Citas Citado por
6
Automatic generation of alloreactivity-reduced donor lymphocytes and hematopoietic stem cells from the same mobilized apheresis product
Automatic generation of alloreactivity-reduced donor lymphocytes and hematopoietic stem cells from the same mobilized apheresis product
Material Type:
Artículo 		Añadir a Mi Portal

Automatic generation of alloreactivity-reduced donor lymphocytes and hematopoietic stem cells from the same mobilized apheresis product

Wiercinska, E ; Quade-Lyssy, P ; Hümmer, C ; Beifuß, J ; Akarkach, K ; Poppe, C ; Olevska, V ; Dzionek, J ; Lahnor, H ; Bosio, A ; Papanikolaou, E ; Bonig, Halvard

Journal of translational medicine, 2023-11, Vol.21 (1), p.849-849, Article 849 [Revista revisada por pares]

England: BioMed Central Ltd

Texto completo disponible

Citas Citado por
7
Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival
Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival
Material Type:
Artículo 		Añadir a Mi Portal

Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival

Cabezón, M ; Malinverni, R ; Bargay, J ; Xicoy, B ; Marcé, S ; Garrido, A ; Tormo, M ; Arenillas, L ; Coll, R ; Borras, J ; Jiménez, M J ; Hoyos, M ; Valcárcel, D ; Escoda, L ; Vall-Llovera, F ; Garcia, A ; Font, L L ; Rámila, E ; Buschbeck, M ; Zamora, L

Clinical epigenetics, 2021-01, Vol.13 (1), p.9-9, Article 9 [Revista revisada por pares]

Germany: BioMed Central Ltd

Texto completo disponible

Citas Citado por
8
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
Material Type:
Artículo 		Añadir a Mi Portal

Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond

Su, Christopher T ; Ye, J. Christine

Journal of hematology and oncology, 2021-07, Vol.14 (1), p.1-115, Article 115 [Revista revisada por pares]

London: BioMed Central Ltd

Texto completo disponible

Citas Citado por
9
Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy
Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy
Material Type:
Artículo 		Añadir a Mi Portal

Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy

Yuan, Ruirong ; Kay, Andrea ; Berg, William J ; Lebwohl, David

Journal of hematology and oncology, 2009-10, Vol.2 (1), p.45-45, Article 45 [Revista revisada por pares]

England: BioMed Central Ltd

Texto completo disponible

Citas Citado por
10
A comprehensive joint analysis of the long and short RNA transcriptomes of human erythrocytes
A comprehensive joint analysis of the long and short RNA transcriptomes of human erythrocytes
Material Type:
Artículo 		Añadir a Mi Portal

A comprehensive joint analysis of the long and short RNA transcriptomes of human erythrocytes

Doss, Jennifer F ; Corcoran, David L ; Jima, Dereje D ; Telen, Marilyn J ; Dave, Sandeep S ; Chi, Jen-Tsan

BMC genomics, 2015-11, Vol.16 (943), p.952-952, Article 952 [Revista revisada por pares]

England: BioMed Central Ltd

Texto completo disponible

Citas Citado por
Resultados 1 2 3 4 5 next page

Personalizar los resultados

  1. Editar

Refine Search Results

Ampliar mis resultados

  1.   

Mostrar solo

  1. Revistas arbitradas (148)

  • Realización: ABCD-USP USP   Logos de Redes Sociales: Freepik

Buscando en bases de datos remotas, por favor espere

  • Buscando por
  • enscope:(USP_VIDEOS),scope:("PRIMO"),scope:(USP_FISICO),scope:(USP_EREVISTAS),scope:(USP),scope:(USP_EBOOKS),scope:(USP_PRODUCAO),primo_central_multiple_fe
  • Mostrar lo que tiene hasta ahora